Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Beximco Pharma (BXP) Share Price

Price 44.00p on 07-10-2025 at 10:50:06
Change 0.00p 0%
Buy 45.00p
Sell 43.00p
Last Trade: Unknown 1,000.00 at 44.00p
Day's Volume: 0
Last Close: 44.00p
Open: 44.00p
ISIN: US0885792061
Day's Range 44.00p - 44.00p
52wk Range: 24.50p - 51.50p
Market Capitalisation: £196.29m
VWAP: 0.00p
Shares in Issue: 446.11m

Beximco Pharma (BXP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,000 44.00p Ordinary
14:03:26 - 06-Oct-25
Sell* 10,000 43.211p Ordinary
10:25:52 - 06-Oct-25
Unknown* 5,000 44.00p Negotiated Trade
15:40:22 - 03-Oct-25
Unknown* -5,000 44.00p Ordinary
Correction
16:25:21 - 02-Oct-25
Unknown* 5,000 44.00p Ordinary
16:25:21 - 02-Oct-25
Buy* 3,400 44.80p Ordinary
15:15:08 - 02-Oct-25
Buy* 2,000 47.00p Ordinary
11:18:01 - 02-Oct-25
Sell* 5,000 44.00p Ordinary
10:33:47 - 02-Oct-25
Sell* 3,000 43.04p Ordinary
10:33:36 - 02-Oct-25
Sell* 6,165 44.09p Ordinary
10:32:46 - 02-Oct-25
See more Beximco Pharma trades

Beximco Pharma (BXP) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Oct 2025 (Mon) 44.00 44.00 44.00 44.00 11,000
3rd Oct 2025 (Fri) 44.00 44.00 44.00 44.00 5,000
2nd Oct 2025 (Thu) 45.50 45.50 44.00 44.00 19,565
1st Oct 2025 (Wed) 45.50 45.50 45.50 45.50 36,500
30th Sep 2025 (Tue) 46.50 46.50 45.50 45.50 11,216
29th Sep 2025 (Mon) 46.50 46.50 46.50 46.50 18
26th Sep 2025 (Fri) 46.50 46.50 46.50 46.50 24,230
25th Sep 2025 (Thu) 46.50 46.50 46.50 46.50 46,505
24th Sep 2025 (Wed) 46.50 46.50 46.50 46.50 850,400
23rd Sep 2025 (Tue) 46.50 46.50 46.50 46.50 60,775
22nd Sep 2025 (Mon) 46.50 46.50 46.00 46.50 39,870
19th Sep 2025 (Fri) 46.50 46.50 46.50 46.50 8,935
18th Sep 2025 (Thu) 46.50 46.50 46.50 46.50 2,015
17th Sep 2025 (Wed) 46.50 47.40 46.50 46.50 27,212
16th Sep 2025 (Tue) 46.50 46.50 46.50 46.50 2,752
15th Sep 2025 (Mon) 46.50 47.40 46.50 46.50 16,843
12th Sep 2025 (Fri) 46.50 46.50 46.50 46.50 0
11th Sep 2025 (Thu) 46.50 46.50 46.50 46.50 12,951
10th Sep 2025 (Wed) 46.50 46.50 46.50 46.50 3,953
9th Sep 2025 (Tue) 46.50 46.50 46.50 46.50 1,561
8th Sep 2025 (Mon) 46.50 46.50 46.50 46.50 1,500
See more Beximco Pharma price history

Beximco Pharma (BXP) Regulatory News

Date Source Headline
15th Sep 2025 1:17 pm RNS Further update on BSEC Order
21st May 2025 3:18 pm RNS Update on BSEC Order
28th Apr 2025 7:00 am RNS Request of Extension to Publish Q3 Results
21st Mar 2025 3:51 pm RNS Response to media reports and update on BSEC order
6th Mar 2025 7:00 am RNS Update on BSEC order
30th Jan 2025 2:59 pm RNS Payment of Cash Dividend
29th Jan 2025 7:01 am RNS Board Changes
29th Jan 2025 7:00 am RNS Half Year Results 2024-25
14th Jan 2025 11:24 am RNS Board of Directors
30th Dec 2024 7:00 am RNS Annual General Meeting Statement
See more Beximco Pharma regulatory news

Beximco Pharma (BXP) Share News

IN BRIEF: Beximco denies "all media allegations of corruption"

21st Mar 2025 16:20

Beximco Pharmaceuticals PLC - Dhaka, Bangladesh-based producer of pharmaceutical ingredients - Releases statement, originally published on Wednesday in Bangladesh, denying allegations of corruption in the Covid-19 vaccine procurement process. Says these allegations circulated in the Bangladeshi media on Monday and Tuesday, following the launch of an anti-corruption commission investigation. Statement says Beximco "is deeply concerned and disappointed by the misleading and defamatory news [reports]", adding: "The company rejects these baseless allegations and protests the sensationalized and slanderous headlines, that not only tarnished corporate reputation as a globally known pharmaceutical manufacturer and exporter but also confused thousands of its valued shareholders, especially many foreign investors who currently hold more than 32% of company's shares." Claims that "several" media outlets "clearly attempted to malign Beximco Pharma". Furthermore, Beximco "firmly asserts that it conducted all transactions with necessary approvals from the regulatory authorities". "Says it reserves the right to take appropriate legal action against such defamatory reporting". Read More

Beximco Pharma petitions board appointments amid fraud allegations

14th Jan 2025 14:32

(Alliance News) - Beximco Pharmaceuticals Ltd on Tuesday said it had issued a petition against nine appointments to its board by the Bangladesh Securities and Exchange Commission. Read More

Beximco Pharmaceuticals says full court hearing set for October 28

2nd Oct 2024 12:12

(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said the Bangladesh court has referred the company's appeal in its recent fraud case to a full-court hearing, which will take place on October 28. Read More

IN BRIEF: Beximco Pharma vice-chair arrested for ties to ousted PM

15th Aug 2024 11:28

Beximco Pharmaceuticals - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Confirms that Vice-Chair Salman Rahman was arrested by Dhaka police on Tuesday and will be held for 10 days while an investigation into alleged offences is carried out. Rahman was a private industry and investment advisor to deposed Bangladesh prime minister Sheikh Hasina, who fled the country earlier this month amid accusations of human rights abuses. Read More

IN BRIEF: Beximco Pharma says Bangladesh unrest reduced distribution

13th Aug 2024 13:44

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. "The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days," Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn't expect the disruption to have a "material impact" on annual results. Read More

See more Beximco Pharma news
FTSE 100 Latest
Value9,489.32
Change10.18

Login to your account

Forgot Password?

Not Registered